Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: TobagoJack who wrote (157259)	4/28/2020 6:24:51 PM
From: THE ANT	Read Replies (1) \| Respond to of 218142

Just a reminder for others on the board that did not follow in the past. SRPT was an antiviral company in the past and developed a drug 100% effective in treating the Marburg virus at the request of the Department of defense. They made an Ebola medication that took mortality in Monkeys from 100% to 50% on the lowest level of the drug.They never increased the dose as the Dept of defense canceled the contract. This was during an outbreak of Ebola in Africa at the time and the cancellation was likely due to the medication being much more expensive than a vaccine. They also in the past made a corona virus drug for some zoo critters within 2 weeks and helped them survive. The delivery molecule is very safe and has never had a serious side effect. Just attach the RNA patch you want to the molecule and you are ready to go. They have a patent for its use in corona viruses. Three "good" patches have been attached to the delivery molecule to treat three different types of DMD. In the case of viruses a "bad" patch is applied to knock out its functioning or reproduction